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Abstract
Background: Task shifting approaches (rational redistribution of tasks among health workforce teams) to train lay
professionals to assist with integrating mental health treatment in primary care has been recommended to close
the mental health treatment gap for depression in low- and middle-income countries. This study aims to examine
the a new model for depression care in a low-resource environment compared to enhanced treatment at usual
(E-TAU).
Methods: We trained non-specialist community health workers (local lay employees of the public health system) to
provide Interpersonal Counseling (IPC) to treat depressive symptoms in the Brazilian, São Paulo city, family health
strategy (FHS). We conducted a randomized controlled trial involving 86 patients with a current major depressive
disorder or dysthymia (based on DSM-IV) recruited from an FHS clinic. Participants were randomized to IPC
intervention (n = 43) or E-TAU (n = 43). Participants allocated to IPC received 3–4 sessions provided by community
health workers; research psychologists followed the E-TAU participants to facilitate their referral to specialized
mental health care within the public system. Reduction of depressive symptoms was assessed using the Hamilton
Rating Scale (HDRS-17) and the Patient Health Questionnaire (PHQ-9); minor psychiatric symptomatology (including
depression, anxiety and somatoform symptoms) were measured using the Self Reporting Questionnaire (SRQ); and
functioning was measured by the Clinical Global Impression Scale over a 2-month period.
Results: Intention-to-treat analysis showed significant improvement on symptoms for both groups over 2 months,
without significant differences between them. Per-protocol analysis showed significant better HDRS-17 outcomes
for the IPC group.
Conclusions: Training non-specialist community health workers in low- and middle-income countries to provide
IPC could be a successful strategy in reducing the burden of depression and also potentially a low-cost and
effective alternative to specialist-led services that might not be possible in low income settings.
Trial registration: Brazilian Clinical Trials, number RBR-5qhmb5 (trial url: http://www.ensaiosclinicos.gov.br/rg/RBR-
5qhmb5/), retrospectively registered after May 1, 2013.
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Background
The World Health Organization (WHO) ranks Major
Depressive Disorder (MDD) as one of the most signifi-
cant challenges for the twenty-first century, because of
its consequent disability and loss of function. MDD is
the leading cause of neuropsychiatric burden of disease
globally [1, 2]. The majority of people with MDD can be
treated early and effectively in primary care [3]; never-
theless MDD is underdiagnosed and undertreated [4–6].
The global mental health treatment gap is more pro-
nounced in low and middle-income countries (LMIC),
where the vast majority of mental health needs is unmet
[7]. There is a large literature supporting psychological
non-pharmaceutical interventions for treating MDD,
which are often preferred by primary care patients
[8–10] and are recommended as first-line treatment
by the international guidelines [11–13].
Brazil’s Family Health Strategy (FHS) has made
remarkable progress towards universal coverage of its
population in primary care in the last decades, but only
limited investments in mental health [14]. Specialized
community-based psychosocial care centers were estab-
lished to provide treatment to individuals with severe
mental illness [15] but no strategies were developed to
integrate the treatment of common mental disorders
within primary care. Community health workers are em-
ployees of the public health system; each one is assigned
to approximately 150 households within the catchment
area of a given FHS outreach clinic. They visit each
household at least once per month and gather informa-
tion about health-promotion activities and basic clinical
care [14]. They are also tasked with identifying potential
warning signs of violence, neglect, truancy or drug use,
but receive no mental health training [16–18]. Commu-
nity health workers are therefore an important human
resource for health in Brazil. Globally, there is an
increased focus on the use of lay community health
workers to meet mental health needs [19–21].
Interpersonal psychotherapy (IPT) is an evidence-
based intervention [13, 22] that has been effectively im-
plemented in low income settings using a task-shifting
approach, wherein non-specialist lay counselors are
trained to deliver the intervention with expert supervi-
sion [23]. The WHO defines task shifting as “the rational
redistribution of tasks among health workforce teams”
[19]. In other words, specific functions are shifted, where
appropriate, from highly qualified health workers to
health workers with shorter training and fewer qualifica-
tions in order to make more efficient use of the available
human resources for health.
Interpersonal counseling (IPC) is derived from IPT,
but is a briefer and more structured version that has
demonstrated effectiveness in a variety of populations
[24], including primary care outpatients [25–28],
medically ill older adults aged 60 or more [29], patients
with psychological distress post major physical trauma
[30], women with breast cancer and their partners
[31–34], men with prostate cancer and their supportive
partners [35], patients with recent myocardial infarctions
[36, 37], and women after miscarriage [38, 39]. IPC has
been effectively delivered by trained health providers that
are not mental health specialists, such as nurses practi-
tioners [28] and doctors [25]. Mental health professionals
have also effectively delivered IPC including psychiatric
nurses [29, 30, 32–34], clinical psychologists [27, 30, 40],
IPT-certified psychotherapists [38], psychiatric social
workers [38], and residents in psychiatry with at least
2 years of clinical experience [27, 40]. However, IPC has
never been task shifted to lay professionals with only a
high school level education. Given the widespread short-
age of mental health specialists in Brazil, the purpose of
this trial was to determine whether IPC delivered by non-
specialist community health workers could achieve
comparable effectiveness to current available services by
mental health specialists within the Brazilian public health
system. To our knowledge, this is the first study to use
IPC with a task shifting approach to train lay professionals
in a low-resource setting.
Methods
Study design
This pragmatic Randomized Controlled Trial (RCT)
sought to treat depressive disorders (current MDD or
Dysthymia) according to American Psychiatric Associa-
tion’s Diagnostic and Statistical Manual of Mental Disor-
ders 4th Edition (DSM-IV). We sought to evaluate
whether IPC, an abbreviated version of IPT with an
abundant evidence base, could effectively be delivered by
lay community health workers. The control group re-
ceived Enhanced Treatment as usual (E-TAU), in which
research psychologists optimized access to mental health
resources available within the public health system.
Setting
The RCT was conducted in the FHS Unidade Básica de
Saúde Iaçapé, Sapopemba, district of São Paulo – Brazil
between May 1, 2013 and April 30, 2015. All consecutive
individuals attending routine visits were screened by the
community health worker for eligibility based on the
specified inclusion/exclusion criteria and randomly
assigned to receive either IPC or E-TAU, using a
parallel-group randomized controlled trial design [1:1].
The Institutional Review Board of the Federal University
of São Paulo and the County Health Council of São
Paulo city approved the study protocol. The trial was
registered at Brazilian Clinical Trials, number RBR-
5qhmb5 (trial url: http://www.ensaiosclinicos.gov.br/rg/
RBR-5qhmb5/).
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Sample
Participation in the study was voluntary without finan-
cial compensation and written informed consent was ob-
tained, in compliance with the Code of Ethics of the
World Medical Association (Declaration of Helsinki)
and the standards of the Review Board and granting
agency. The inclusion criteria for the clinical trial were:
(1) aged 18 or older; (2) positive screening for probable
depressive disorder using the Zung scale [41] adminis-
tered by community health workers with scale score
confirmed by research psychologists; and (3) diagnosis
by a research psychologist of current MDD or dysthymia
using the Mini-International Neuropsychiatric Interview
(MINI), a structured clinical diagnostic instrument based
on the Diagnostic and Statistical Manual IV [42]. Exclu-
sion criteria were: (1) ongoing treatment with antide-
pressants or psychotherapy; or (2) suicide risk evaluated
by the MINI; or (3) current/previous episodes of mania,
hypomania or current/previous psychotic symptoms, al-
cohol or psychoactive substance use disorder according
to the MINI.
Depression screening
Two authors (CTM and RFB) facilitated a 1-day training
to 42 community health workers within the catchment
area. We discussed the diagnosis criteria of MDD
(DSM-IV) and practiced administration of the instru-
ment Zung self-rating depression scale [41]. Although
the scale can be self-administered, given the low literacy
of the target population, community health workers
were trained to administer all questions to recruit partic-
ipants. The community health workers were employees
of the County Health Council of São Paulo city, and
there was no additional monetary compensation pro-
vided to screen participants.
Interpersonal counseling (IPC)
IPC seeks to address patients’ current psychological
problems and social within four interpersonal problem
areas: prolonged grief, interpersonal disputes, role transi-
tions and interpersonal deficits. Following the manual
[28, 43], IPC comprised a 1-h session per week, with 3–4
sessions in total. Sessions were provided either at the
clinic or in household visits, based on the individual’s
preference. The community health workers facilitating
IPC were not workers in the catchment area in which the
patients resided to ensure confidentiality and prevent
interference in their usual roles. We conducted a 3-day
training to the 42 community health workers employed at
the Health Unit, divided into three groups. Two of the au-
thors (CTM and RFB, interpersonal therapists) facilitated
the training using the Revised IPC Manual [43]. The train-
ing included research ethics and confidentiality, depres-
sion education with interactive activities, and role-playing
of IPC techniques. Although all 42 community health
workers had participated in the training, 20 were selected,
according to motivation and empathy skills observed by
the facilitators. They were supervised through the trial by
the same trainers in 2 different groups in 2-h long twice a
month supervision meetings. Supervisors were also
available by telephone, mobile messages or email. These
selected community health workers received a monetary
compensation for each session completed.
Enhanced treatment as usual (E-TAU)
FHS primary-care clinics usually have no mental health
professionals employed onsite and referrals are required,
however, this additional step often serves as a barrier for
individuals to access treatment. We designed this arm to
facilitate patients’ referral to specialized mental health
care within the public system. Individuals randomized to
E-TAU were provide case-management by off-site
research psychologists funded by the study that were not
trained in IPC. Research psychologists reported cases to
FHS and facilitated referrals to specialized mental health
care centers within the public system, where IPC is not
provided, to receive either pharmacological or psycho-
logical treatment. The assigned research psychologist
made 2–3 phone calls to the patient to check on the
referral status and ensure follow-up. We considered E-
TAU as received when a patient followed the task to
complete the referral, even if there was a waiting list for
treatment.
Instruments
Research psychologists collected standard demographic
information and administered the following instruments.
1- Pre-screening:
Zung Self-Rating Depression Scale [41]: A 20-item self-
report questionnaire covering affective, psychological and
somatic symptoms associated with depression. A total
score ranges from 20 to 80, and we use a cutoff point
of ≥45 as inclusion criteria, according to the validated
Brazilian version [44].
Mini-International Neuropsychiatric Interview (MINI)
[42]: A short semi-structured diagnostic interview based
on DSM-IV criteria was used to confirm clinical diag-
noses prior to the intervention. We used a version
validated for use in Brazil [45, 46] and included the fol-
lowing modules: MDD, Dysthymia, Generalized Anxiety
Disorder, Panic Disorder, Agoraphobia, Social Phobia
and Post-Traumatic Stress Disorder.
2- Primary outcomes: (assessed at baseline and at
2-month follow-up visit)
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Health Questionnaire 9-item screen (PHQ-9) [47]: A
self-report measure of depression administered by the
research psychologist to assess depressive symptoms
over the past two weeks. Total scores on the scale range
from 0 to 27 and recommended severity classifies people
as having no (0–4), mild (5–9), moderate (10–14),
moderately severe (15–19) or severe (20–27) depression.
We used the Brazilian version translated and validated
for use with primary care patients [48].
Hamilton Depression Rating Scale (HDRS-17) [49]:
The 17-item version is a clinician-rated scale that
determines the severity of each symptom during the past
week. Total scores range from 0 to 52, and the American
Psychiatric Association’s Handbook of Psychiatric
Measures [50] defines its grades of severity as mild
depression (8–13), moderate depression (14–18), severe
depression (19–22), and very severe depression (≥23).
We used the translated Brazilian version [51].
The primary outcome of this study was the reduction
of scores in PHQ-9 [47] and HDRS-17 [49]. Full remis-
sion of the depressive disorder was defined as an HDRS-
17 score of 8 or less [52]. Following Hollon et al. [53],
HDRS-17 scores ≤12 were considered to meet criteria
for partial remission.
3- Secondary outcomes: (assessed at baseline and at
2-month follow-up visit)
The Self-Reporting Questionnaire (SRQ-20) [54] was
specifically developed by WHO to identify minor psychi-
atric morbidity in primary care and community settings
in developing countries. It includes 20 dichotomous
items covering depressive, anxiety and somatic symp-
toms. We used a cutoff of ≥8 for positive cases accord-
ing to the translated Brazilian version [55].
The Clinical Global Impression instrument (CGI) [56]
provides an overall score of the clinician’s view of the
patient’s symptoms, behavior and functioning following
a seven-point scale for one question. It ranges from 1
(normal) to 7 (extremely severe symptoms).
For secondary outcomes, we analyzed changes in the
scores of the SRQ-20 [54, 55] and CGI [56].
Randomization
Randomization (allocation ratio 1:1) was stratified by
gender, age (17–34 vs. ≥35), and depression severity
(Zung score 45–59 vs. ≥60). A statistician not in-
volved in the recruitment process carried out the
randomization using a computer algorithm based on
Aitchison’s compositional distance [57]. Only the re-
search assistant knew the group allocation. Evaluators
at follow up were blinded to which intervention was
received.
Statistical analyses
We performed the analyses using the intention-to-treat
approach. Descriptive statistics included mean and
standard deviation (SD) for continuous variables, and
frequencies for categorical or ordinal variables. Compari-
sons between the two groups (IPC vs. E-TAU) were
performed using Student’s t-test for continuous vari-
ables, and cross-tabulation with χ2 test for categorical or
ordinal variables. Statistical Package for the Social
Sciences (SPSS) version 23 [58] was used to perform
these analyses. Given the relatively small sample size, we
tested group differences on primary and secondary out-
comes using Latent Growth Model (LGM) and Bayesian
estimator [59]. Goodness-of-fit of the models was evalu-
ated using the Posterior Predictive P-values (PPP), which
should be close to 0.5. Mplus 7.4 was used to perform
these analyses.
When performing LGM, Mplus estimates a slope
representing the mean change over time in the outcome.
Group differences were estimated by regressing the slope
on a binary variable identifying the two groups IPC vs.
E-TAU (0/1). The effect size was calculated using the
Independent-Groups Pretest-Posttest formula described
in Feingold [60]. Later, we performed a per-protocol
analysis for primary outcomes, i. e. involving only those
patients who completed the intervention originally
assigned.
Results
A diagram of participant flow is depicted in Fig. 1. A
total of 261 patients were recruited, 175 excluded for
not meeting eligibility criteria (n = 173) or declined to
participate (n = 2) and 86 patients were randomized to
IPC (n = 43) or E-TAU group (n = 43). Of the 43
patients that were selected to receive IPC, 38 received a
mean 2.26 (±1.26) sessions. Twenty-five (58.14%) re-
ceived three or four sessions. Thirteen (30.23%) patients
attended one or two sessions. Five (11.63%) did not at-
tend any sessions: 1 declined (2.33%) and 4 were lost to
follow-up (n = 4; 9.30%). Among the 43 patients selected
for E-TAU, 26 (60.50%) received the allocated interven-
tion: 13 (30.25%) engaged in treatment (pharmacother-
apy or psychological) available in the public system and
13 (30.25%) were on waiting lists for treatment.
Seventeen (39.50%) did not receive any intervention,
either because they did not pursue the treatment referral
(n = 14; 32.56%) or were considered lost to follow up
(n = 3; 6.94).
Demographic characteristics of the study population
are described in Table 1. The two groups had similar
clinical profiles at baseline (see Table 2). No differences
in gender, age, ethnicity, education, religion and social-
economical class were observed between the IPC and E-
TAU group.
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For the total sample (N = 86), the mean total score of
PHQ-9 at baseline was 16.80 (±5.06) and the mean total
score of HDRS-17 was 17.13 (±5.79). All patients in-
cluded in the study met diagnostic criteria for a depres-
sive disorder: current Major Depressive Episode (n = 81;
94.20%) or Dysthymia (n = 6; 7.00%), accordingly to clin-
ical assessment using the MINI. Only one patient met
both diagnostic criteria. Thirty (34.90%) had recurrent
Major Depressive Episode and 51 (59.30%) presented the
first single Major Depressive Episode. Forty-eight
(55.80%) met criteria for MDD with melancholic fea-
tures. Twenty-eight (32.60%) had at least one psychiatric
comorbidity with depressive disorder such as General-
ized Anxiety Disorder, Panic Disorder, Agoraphobia,
Social Phobia, Obsessive Compulsive Disorder or Post-
Traumatic Stress Disorder. IPC group had higher
frequency of current Major Depressive Episode than E-
TAU group (100.00% vs. 88.40%; ϰ2 = 5.31; p = 0.02),
which was the only clinical profile difference at baseline.
The fit of the four LGMs was good (PPP close to .50;
see Table 3). The results of the analysis (LGM) did not
show statistically significant differences between the
two groups (IPC vs. E-TAU) (see Table 3) for primary
and secondary outcomes. However, the differences
approached statistical significance (i.e. p < .10) that
can be interpreted as trends towards medium effect
sizes. Overall, both groups showed significant
improvement on depressive symptoms (HDRS-17 and
PHQ-9), with lower SRQ-20 and CGI score after
2 months.
In the IPC group, 11 (28.21%) participants achieved
complete remission (HDRS-17 score ≤ 8) compared to 9
(22.50%) participants of E-TAU group, with no differ-
ence between the two groups (ϰ2 = 0.34; p = 0.56).
Partial remission (HDRS-17 score ≤ 12) was achieved by
16 (41.03%) from IPC group vs. 17 (42.50%) from E-
TAU group, with no difference between the two groups
(ϰ2 = 0.02; p = 0.89). In IPC group, 10 (25.64%) partici-
pants achieved response to treatment (50% reduction of
symptoms) and 6 (15.38%) from E-TAU group, with no
difference between the two groups (ϰ2 = 1.26; p = 0.26).
Primary outcomes are graphically shown in Figs. 2 and 3.
To investigate these results further we applied a per-
protocol analysis for those patients who completed the
intervention as intended (IPC n = 25 vs. E-TAU n = 26).
Primary outcomes were analyzed. Regarding the HDRS-
17, the fit of the LGM was good (PPP = 0.42), and the
results showed a statistically significant difference
between the two groups (IPC vs. E-TAU), see Table 4
and Fig. 4. Regarding the PHQ-9 scale, the fit of the
Fig. 1 CONSORT flow diagram. IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as Usual group
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LGM was good (PPP = .42), and the results did not show
a statistically significant difference between the two
groups (IPC vs. E-TAU), see Table 4. Change over time
in all groups showed significant improvement on depres-
sive symptoms based on HDRS-17 and PHQ-9 scores.
Discussion
This trial demonstrates that training community health
workers using a task shifting approach to improve MDD
symptoms is not only acceptable and feasible, but can
achieve comparable positive results to an optimized
treatment as usual with case management by psycholo-
gists. This is consistent with other studies suggesting the
potential effectiveness of community health workers’
psychosocial and psychological interventions [19, 20].
Whereas intention-to-treat analysis showed significant
improvement on symptoms for both groups over
2 months, without significant differences between them,
per-protocol analysis resulted in a significantly better
outcome for the IPC group. Providing mental health
services, including evidenced-based interventions, in
primary care clinics or systems can be done in many
different ways. Traditionally, many clinics opt to refer
patients to specialists as needed. However, the imple-
mentation is challenging because it is not always feasible
to employ on-site care managers to enhance referral, so
Table 1 Demographic characteristics of the study population
Total IPC group E-TAU group
N = 86 n = 43 n = 43 Statistics p
Age, years: mean (s.d.) 43.84 (14.76) 46.42 (15.22) 41.26 (13.99) t = 1.64 .11
Gender, female: n (%) 81 (94.20) 40 (93.00) 41 (95.30) ϰ2 = 0.21 .65
Race/ethnicity: n (%) ϰ2 = 4.22 .24
African American/Black 8 (9.30) 4 (9.30) 4 (9.30)
White/Caucasian 36 (41.90) 19 (44.20) 17 (39.50)
Biracial/Multiracial 38 (44.20) 20 (46.50) 18 (41.90)
Other 4 (4.70) 0 (0.00) 4 (9.30)
Marital status: n (%) ϰ2 = 3.11 .08
Not partnered 34 (39.50) 13 (30.20) 21 (48.80)
Number of children: ϰ2 = 2.83 .59
0 25 (29.10) 11 (25.60) 14 (32.60)
1 31 (36.00) 18 (41.90) 13 (30.20)
2 24 (27.90) 10 (23.30) 14 (32.60)
≥3 6 (7.00) 4 (9.30) 2 (4.60)
Education: n (%) ϰ2 = 4.16 .13
< High school degree 51 (59.30) 30 (69.80) 21 (48.80)
High school degree or equivalent 28 (32.60) 11 (25.60) 17 (39.50)
Education beyond high school degree 7 (8.10) 2 (4.70) 5 (11.60)
Religion: n (%) ϰ2 = 2.11 .55
Catholic 32 (37.20) 16 (37.20) 16 (37.20)
Protestant 35 (40.70) 18 (41.90) 17 (39.50)
Other 5 (5.80) 1 (2.30) 4 (9.30)
None 14 (16.30) 8 (18.60) 6 (14.00)
Socio-economical classa: n (%) ϰ2 = 6.18 .19
A1/A2 2 (2.30) 2 (4.70) 0 (0.00)
B1/B2 21 (24.40) 12 (27.90) 9 (20.90)
C1/C2 48 (55.80) 19 (44.20) 29 (67.50)
D 9 (10.50) 6 (14.00) 3 (7.00)
E 6 (7.00) 4 (9.30) 2 (4.70)
Household monthly incomeb (US$): mean (s.d.) 687.74 (603.79) 785.10 (746.07) 595.37 (417.37) t = 1.38 .17
aABIPEME Brazilian socio-economical class classification
bConversion R$ 1.00 (reais) = US$ 3.5 (dollar), August 2015.
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training on-site providers in evidenced-based interven-
tions could be a better option, also in terms of accept-
ability. IPC group had better acceptability with only 1
(2.33%) patient declining to participate versus 14
(32.56%) that did not pursue the treatment referral in
the E-TAU group.
To date, IPC has been studied in diverse popula-
tions with highly trained health workers as providers
[24]. The only large IPC trial with a sample of 287
patients showed robust results when IPC was
delivered by clinical psychologists or psychiatric resi-
dents with a minimum of 2 years of clinical experi-
ence [26, 27]. Our study demonstrates that task
shifting IPC to lay community health workers can
achieve comparable results to E-TAU. Although the
research psychologists from the E-TAU group did not
offer any standardized treatment, their engagement
increased clinical attention, an effect not present in
routine clinical care, which could explain positive out-
comes in the control group.
Table 2 Clinical characteristics of the study population at baseline
Total IPC group E-TAU group
N = 86 n = 43 n = 43 Statistics p
Zung Total: mean (s.d.) 53.47 (6.69) 54.28 (7.49) 52.65 (5.75) t = 1.28 .26
HDRS-17 severity: N (%) ϰ2 = 6.15 .19
Normal (0–7) 3 (3.50) 0 (0.00) 3 (7.00)
Mild (8–13) 18 (20.90) 9 (50.00) 9 (50.00)
Moderate (14–18) 30 (34.90) 13 (30.20) 17 (39.50)
Severe (19–22) 21 (24.40) 11 (25.60) 10 (23.30)
Very severe (≥23) 14 (16.30) 10 (23.30) 4 (9.30)
HDRS-17 Total score: mean (s.d.) 17.13 (5.79) 18.30 (5.83) 15.93 (5.56) t = 3.69 .06
PHQ-9 severity: N (%) ϰ2 = 2.93 .57
Minimal (0–4) 1 (1.20) 0 (0.00) 1 (2.30)
Mild (5–9) 6 (7.00) 3 (7.00) 3 (7.00)
Moderate (10–14) 21 (24.40) 10 (23.30) 11 (25.60)
Moderately severe (15–19) 32 (37.20) 14 (32.60) 18 (41.90)
Severe (20–27) 26 (30.20) 16 (37.20) 10 (23.30)
PHQ-9 Total score: mean (s.d.) 16.80 (5.06) 17.58 (5.16) 16.02 (4.89) t = 2.07 .16
SRQ: mean (s.d.) 13.55 (3.46) 13.79 (3.52) 13.30 (3.41) t = 0.43 .52
CGI: mean (s.d.) 4.70 (0.77) 4.53 (0.67) 4.86 (0.83) t = 1.92 .06
MINI (DSM-IV and ICD-10): N (%)
Depressive Disorder 86 (100.00) 43 (100.00) 43 (100.00) ϰ2 = 0.00 1.0
Major Depressive Episode, current 81 (94.20) 43 (100.00) 38 (88.40) ϰ2 = 5.31 .02
MDE, recurrent 30 (34.90) 15 (34.90) 15 (34.90) ϰ2 = 0.00 1.0
MDE, single episode 51 (59.30) 28 (65.10) 23 (53.50) ϰ2 = 1.20 .27
Dysthymia 6 (7.00) 1 (2.30) 5 (11.60) ϰ2 = 2.87 .09
MDD + Dysthymia 1 (1.20) 1 (2.30) 0 (0.00) ϰ2 = 1.01 .31
MDE with melancholic features 48 (55.80) 26 (60.50) 22 (51.20) ϰ2 = 0.75 .39
Comorbidity with DD 28 (32.60) 12 (27.90) 16 (37.20) ϰ2 = 0.85 .36
Generalized Anxiety Disorder 7 (8.10) 3 (7.00) 4 (9.30) ϰ2 = 0.16 .69
Panic Disorder 5 (5.80) 2 (4.70) 3 (7.00) ϰ2 = 0.21 .64
Agoraphobia 11 (12.80) 5 (11.60) 6 (14.00) ϰ2 = 0.10 .75
Social Phobia 6 (7.00) 3 (7.00) 3 (7.00) ϰ2 = 0.00 1.0
Obsessive Compulsive Disorder 1 (1.20) 1 (2.30) 0 (0.00) ϰ2 = 1.01 .31
Post-Traumatic Stress Disorder 6 (7.00) 2 (4.70) 4 (9.30) ϰ2 = 0.72 .40
HDRS-17 – 17-item Hamilton Depression Rating Scale, PHQ-9 – Patient Health Questionnaire, SRQ-20 – Self-Reporting Questionnaire, CGI – Clinical Global Impression
instrument, MINI − Mini-International Neuropsychiatric Interview, MDE – Major Depressive Episode; IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as
Usual group
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Despite finding low remission rates in HDRS-17
(28.21% in IPC group and 22.50% in E-TAU group), it is
known that only about a third of patients with an
episode of MDD may remit with a given treatment [61].
Although IPC is proven to be more efficacious than se-
lective serotonin reuptake inhibitors (SSRIs) in primary
care patients with mild to moderate depression [27], in
our sample 40.70% exhibited severe to very severe
depression according to HDRS-17 (≥19) and also
responded to treatment. This high MDD severity was
not expected for a primary care setting, nevertheless it
suggests possible bias for our intervention outcomes
since the slightly lower remission rates in HDRS-17 and
other overall results may be because of a particularly
symptomatic population. According to our study design,
the patients were recruited in the community because
most of them would not seek care spontaneously at the
FHS clinic. The severity of symptoms among patients re-
cruited also calls attention to the needs for depression
screening and earlier treatment.
When we further investigated using a per-protocol
analysis, including only completers of IPC and E-TAU,
we found a statistically significant difference with greater
Table 3 Intention-to-treat analysis. Mean scores (SD) by allocated intervention and observation time
Outcome Baseline
IPC (n = 43)
E-TAU (n = 43)
2-month
IPC (n = 39)
E-TAU (n = 40)
PPP Δ Time by
group (beta)
p CI (95%)a Δ Time
(beta)
p CI (95%)a Effect size
HDRS-17
IPC 18.30 (5.83) 13.31 (7.08) .46 2.23 .08 −.78 to 5.24 −1.23 .05 −2.71 to −.25 0.08
E-TAU 15.93 (5.56) 13.03 (6.56)
PHQ-9
IPC 17.58 (5.16) 11.36 (6.98) .45 .99 .09 −.31 to .02 −2.56 <.001 −3.29 to −1.84 0.10
E-TAU 16.02 (4.89) 11.83 (5.67)
SRQ-20
IPC 13.79 (3.52) 9.67 (5.46) .46 .74 .09 −0.34 to 1.84 −1.70 <.001 −2.25 to −1.14
E-TAU 13.30 (3.41) 10.65 (4.40)
CGI
IPC 4.86 (0.83) 3.21 (1.22) .46 .12 .21 −.19 to .42 −.76 <.001 −.92 to −.61
E-TAU 4.53 (0.67) 3.12 (1.21)
aStudent’s t-test
HDRS-17 – 17-item Hamilton Depression Rating Scale, PHQ-9 – Patient Health Questionnaire, SRQ-20 – Self-Reporting Questionnaire,
CGI – Clinical Global Impression instrument, IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as Usual group
Δ Time by group = change overtime in between groups (IPC vs. E-TAU)
Δ Time = change overtime within group
PPP = posterior predictive p-value
Fig. 2 Intention-to-treat analysis. Mean scores of HDRS-17 by
allocated intervention and observation time. HDRS-17 – 17-item
Hamilton Depression Rating Scale, IPC – Interpersonal Counseling
group, E-TAU – Enhanced Treatment as Usual group. Change
overtime in between groups: Beta 2.23; p = 0.08; CI (95%) = −0.78 to
5.24. Change overtime within group: Beta −1.23; p = 0.05; CI
(95%) = −2.71 to −0.25
Fig. 3 Intention-to-treat analysis. Mean scores of PHQ-9 by allocated
intervention and observation time. PHQ-9 – Patient Health Questionnaire,
IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as
Usual group Change overtime in between groups: Beta 0.99; p = 0.09; CI
(95%) = −0.31 to 0.02. Change overtime within group: Beta −2.56;
p = <0.001; CI (95%) = −3.29 to −1.84
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improvement for the IPC group on HDRS-17, but not
based on PHQ-9 score. We opted to use the PHQ-9 as
it is faster to administer, less complicated to score and
could be applied to a broader range of practice settings,
even though HDRS-17 has been the criterion standard
outcome measure used in clinical trials [62, 63].
At the end of the study, 18 community health workers,
of the 20 that were selected, had actively participated
throughout. Many community health workers reported
empowerment and better understanding of mental
health issues after receiving the training and following
patients in their daily lives. Therefore, it’s possible that
training community health workers in mental health
could also be a way to enhance prevention and reduce
mental health stigma in the community [21, 64].
We acknowledge some limitations of the present
study. First, this was a pilot study with a small sample
and effect size, where patients were recruited from a sin-
gle FHS catchment area. Also, whereas inclusion criteria
and randomization were based on depression symptoms
from the Zung screening scale, outcomes were measured
using different scales. We also had low compliance rates,
with 58.14% completing the 3–4 sessions of IPC and
60.50% completing referral based on E-TAU protocols,
which could have been related to cultural stigma, reli-
gious beliefs or socioeconomically vulnerability in this
population, or not being accustomed to valuing mental
health beyond other subsistence needs. That said, low
adherence is commonly observed in LMIC settings, and
studies have shown that fewer than 40% of adults enter-
ing psychotherapy ever receive more than 3 to 5 sessions
[24]. Our results support the feasibility, acceptability,
and potential effectiveness of a short treatment provided
by community health workers compared to traditional
psychotherapy.
Conclusions
Immediate action is required to reach out to individuals
with depression in primary care. Using an intention-to-
treat analysis, both arms, training on-site community
health workers in IPC or enhancing referral, were
effective methods to improve depressive symptoms. Per-
protocol analysis resulted in a significantly better
outcome for the IPC group. The results point to the
Table 4 Per-protocol analysis. Mean scores (SD) by allocated intervention and observation time
Outcome Baseline
IPC (n = 25)
E-TAU (n = 26)
2-month
IPC (n = 25)
E-TAU (n = 25)
PPP Δ Time by
group (beta)
p CI (95%)a Δ Time
(beta)
p CI (95%)a Effect size
HDRS-17
IPC 17.80 (5.66) 11.76 (6.27) .42 2.68 .00 .86 to 4.46 −1.71 .00 −2.69 to −.73 0.14
E-TAU 16.28 (5.89) 15.32 (6.10)
PHQ-9
IPC 17.00 (5.83) 12.29 (5.61) .42 −.61 .29 −2.79 to 1.59 −2.56 <.001 −3.62 to −1.49 0.25
E-TAU 16.65 (4.92) 10.86 (7.06)
aStudent’s t-test
HDRS-17 – 17-item Hamilton Depression Rating Scale, PHQ-9 – Patient Health Questionnaire, SRQ-20 – Self-Reporting Questionnaire,
CGI – Clinical Global Impression instrument, IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as Usual group
Δ Time by group = change overtime in between groups (IPC vs. E-TAU)
Δ Time = change overtime within group
PPP = posterior predictive p-val
Fig. 4 Per-protocol analysis. Mean scores of HDRS-17 of completers by allocated intervention and observation time. HDRS-17 – 17-item Hamilton
Depression Rating Scale, IPC – Interpersonal Counseling group, E-TAU – Enhanced Treatment as Usual group. Change overtime in between
groups: Beta 2.68; p = 0.003; CI (95%) = 0.86 to 4.46. Change overtime within group: Beta −1.71; p = 0.001; CI (95%) = −2.69 to −0.73
Matsuzaka et al. BMC Psychiatry  (2017) 17:225 Page 9 of 11
need for larger trials with longer follow-up period to
verify the long-term effectiveness of IPC in primary care.
This could be a key strategy for closing the mental
health treatment gap in the Brazilian FHS and other
LMICs.
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